ABVC BioPharma, Inc. (ABVC)
0.8499
-0.01
(-0.89%)
USD |
NASDAQ |
Sep 01, 12:59
ABVC BioPharma Net Income (TTM) : -7.600M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.600M |
| March 31, 2026 | -9.123M |
| December 31, 2025 | -8.377M |
| September 30, 2025 | -5.232M |
| June 30, 2025 | -3.636M |
| March 31, 2025 | -2.350M |
| December 31, 2024 | -4.334M |
| September 30, 2024 | -7.792M |
| June 30, 2024 | -10.67M |
| March 31, 2024 | -11.94M |
| December 31, 2023 | -10.91M |
| September 30, 2023 | -12.08M |
| June 30, 2023 | -12.49M |
| March 31, 2023 | -12.12M |
| December 31, 2022 | -16.31M |
| September 30, 2022 | -13.70M |
| June 30, 2022 | -11.97M |
| March 31, 2022 | -11.22M |
| September 30, 2021 | -10.10M |
| June 30, 2021 | -10.35M |
| March 31, 2021 | -10.48M |
| December 31, 2020 | -10.59M |
| September 30, 2020 | -6.740M |
| June 30, 2020 | -5.939M |
| March 31, 2020 | -4.369M |
| Date | Value |
|---|---|
| December 31, 2019 | -3.933M |
| September 30, 2019 | -6.745M |
| June 30, 2019 | -6.103M |
| March 31, 2019 | -6.224M |
| December 31, 2018 | -6.064M |
| September 30, 2018 | -2.518M |
| June 30, 2018 | -5.692M |
| March 31, 2018 | -5.174M |
| December 31, 2017 | -4.671M |
| September 30, 2017 | -14.94M |
| June 30, 2017 | -11.38M |
| December 31, 2016 | -17.77M |
| September 30, 2016 | -21.06M |
| June 30, 2016 | -10.43M |
| March 31, 2016 | -10.14M |
| December 31, 2015 | -3.533M |
| September 30, 2015 | -0.0323M |
| June 30, 2015 | -0.0254M |
| March 31, 2015 | -0.024M |
| December 31, 2014 | -0.0251M |
| September 30, 2014 | -0.0241M |
| June 30, 2014 | -0.0001M |
| March 31, 2014 | -0.0359M |
| December 31, 2013 | -0.1402M |
| September 30, 2013 | -0.294M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Anika Therapeutics, Inc. | -3.121M |
| Perspective Therapeutics, Inc. | -116.63M |
| MiMedx Group, Inc. | 6.239M |
| Abbott Laboratories | 5.405B |
| AngioDynamics, Inc. | -36.74M |